Referenser Hidradenit

  1. Zouboulis CC et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015; 29:619-44.
  2. Woodruff CM et al. Hidradenitis suppurativa: A guide for the practicing physician. Review. Mayo Clin Proc. 2015; 90: 1679-1693.
  3. Riis PT et al. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series. J Am Acad Dermatol. 2016; 75:1151-5.
  4. Behandling av akne-behandlingsrekommendation. Information från Läkemedelsverket 4: 2014.
  5. Zouboulis C, Bechara F, Dickinson-Blok J, Gulliver W, Horváth B et al. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol 2019;33:19-31.
  6. Goldburg S, Strober B, Payette M. Hidradenitis suppurativa. Current and emerging treatments. J Am Acad Dermatol 2020;82:1061-82.
  7. Regionala riktlinjer 2020-12-31, https://vardgivare.skane.se/vardriktlinjer/hud-och-kon/ako/hidradenitis-suppurativa/
  8. Orenstein L, Nguyen T, Damiani G, Sayed C, Jemec G, Hamzavi I. Medical and Surgical Management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice. Dermatology 2020;236:393-412
  9. Killasli H, Sartorius K, Emtestam L, Svensson Å. Hidradenitis suppurativa in Sweden: A registry-based cross-sectional study of 13538 patients. Dermatology 2020,236:281-288.
  10. Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jernec G. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol 2021;35:50-61.
  11. Vinding G, Miller I, Zarchi K et al. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 2014; 170:884-889.
  12. Chemyshov P, Zouboulis C, Tomas-Aragones L, Jemec G, Svensson A et al. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on quality of life and patient-oriented outcomes and acne, rosacea and hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2019;33:1633-1643.
  13. Hasan S, Harris C, Collier F Hidradenitis suppurativa BMJ: 2022 ;379:e068383
  • Senast uppdaterad: 2022-12-29

Fick du hjälp av informationen på sidan?

Tack för din hjälp att förbättra webbplatsen, dina synpunkter har skickats till webbredaktionen.